MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinsonism"

  • MDS Virtual Congress 2020

    Improved verb use in Parkinson’s disease following intensive voice treatment

    A. Ramage, C. Fox, A. Halpern, L. Ramig (Durham, NH, USA)

    Objective: To identify changes in language production secondary to voice treatment in speakers with Parkinson’s disease (PD). Background: ​Given the role of voice in language…
  • MDS Virtual Congress 2020

    The development and application of an adjunct genetic counseling pre-test assessment and video intervention for Parkinson’s disease (PD)

    S. Elango, V. Katsnelson, D. Raymond, S. Rodriguez, T. Lin, N. Urval, R. Ortega, S. Bressman, R. Saunders-Pullman (New York, NY, USA)

    Objective: To develop a method to improve the efficiency of genetic counseling for PD in a multiethnic cohort, with focus on development and assessment of…
  • MDS Virtual Congress 2020

    Parkinson’s disease polygenic risk prediction and haplotype analysis in a South American cohort

    D. Loesch, A. Horimoto, E. Sarihan, M. Cornejo-Olivas, L. Torres, M. Inca-Martinez, P. Mazzetti, C. Cosentino, E. Dieguez, V. Raggio, A. Lescano, V. Tumas, V. Borges, H. Ferraz, C. Rieder, A. Schumacher-Schuh, B. Lopes Santos-Lobato, C. Velez-Pardo, M. Jimenez-Del-Rio, F. Lopera, P. Chana-Cuevas, W. Fernandez, G. Arboleda, H. Arboleda, C. Arboleda-Bustos, D. Yearout, C. Zabetian, T. Thornton, T. O'Connor, I. Mata (Baltimore, MD, USA)

    Objective: We aim to evaluate the performance of a Parkinson’s disease (PD) polygenic risk score (PRS), estimated using genome-wide association (GWAS) data from a European…
  • MDS Virtual Congress 2020

    TET2-mediated Cdkn2A DNA hydroxymethylation in dopaminergic neuronal injury of Parkinson’s disease

    Y.C Wu, TT. Wu, X. Li, T. Liu (Shanghai, China)

    Objective: Studies have shown that 5-hmC modification is the reverse reaction of DNA methylation, and that this process is regulated by TET family hydroxylases, but…
  • MDS Virtual Congress 2020

    Profile of miRNA expression in CSF of Parkinson’s disease identifies miR-409-3p regulating the apoptosis of dopamine neurons

    X.L Tan, J.Q Tan, F.Y Ming, LL. Lv, H.N Zhang, B.S Tang, W.Q Yan, RR. Bai, X.K Peng, Q.L Xiao, C.Y Wang (Changsha, China)

    Objective: To improve the precise diagnosis of PD at early stage requires more feasible and objective methods. MicroRNA (miRNA) was believed to be a potential…
  • MDS Virtual Congress 2020

    Quantification of 123I-ioflupane Striatal Uptake and Individual Patient Diagnostic Predictions: Degenerative Parkinson’s disease, Non-Degenerative Parkinsonism and Tremor Disorders

    N. Heng, T. Gilbertson, M. Muqit, D. Steele (Dundee, United Kingdom)

    Objective: To develop a fully automated quantitative method to analyse routinely acquired 123I-ioflupane (DaTSCAN) data to aid diagnostic predictions in patients with Parkinson’s disease, non-degenerative…
  • MDS Virtual Congress 2020

    Retinal Pathology in Parkinson’s Disease: A Longitudinal Study with Optical Coherence Tomography

    F. Euler, D. Batra, J. Kassubek, E. Pinkhardt (Ulm, Germany)

    Objective: The aim of this study was to find retinal pathology in Parkinson’s disease (PD) via Optical Coherence Tomography (OCT) that deteriorates over time, as…
  • MDS Virtual Congress 2020

    In vivo markers of anxiety in drug-naïve Parkinson’s disease

    H. Wilson, E. de Natale, M. Politis (London, United Kingdom)

    Objective: To investigate imaging and CSF markers of disease pathology associated with anxiety in drug-naïve idiopathic Parkinson’s disease (PD) patients. Background: Anxiety is a frequent…
  • MDS Virtual Congress 2020

    Subclinical cardiac autonomic dysfunction in patients with Parkinson’s disease: A pilot study

    T.N Sathyaprabha, G. Inbaraj, N. Kuravatti, M.R Rukmani, B.S Krishnaprasad, R. Ravi, K. Mrudula, P. John (Bangalore, India)

    Objective: The aim of this study is to assess cardiac autonomic dysfunction in Parkinson’s disease (PD) patients. Background: Autonomic nervous system dysfunction (AD) is a…
  • MDS Virtual Congress 2020

    Long-term quality of life after subthalamic deep brain stimulation depends on non-motor symptoms in Parkinson’s disease

    S. Jost, L. Timmermann, A. Rizos, M. Silverdale, J. Evans, P. Loehrer, M. Samuel, J. Petry-Schmelzer, A. Sauerbier, M. Barbe, G. Fink, V. Visser-Vandewalle, K. Ashkan, A. Antonini, P. Martinez-Martin, K. Ray Chaudhuri, H. Dafsari (Cologne, Germany)

    Objective: To predict 36-month follow-up quality of life (QoL) outcome after bilateral subthalamic nucleus deep brain stimulation (STN-DBS) in Parkinson’s disease (PD). Background: STN-DBS improves…
  • « Previous Page
  • 1
  • …
  • 70
  • 71
  • 72
  • 73
  • 74
  • …
  • 388
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Marc Chagall’s L’homme à La Tète Renversée (Man with His Head Thrown Back) – An Artistic Depiction of Severe Retrocollis in Neurodegeneration with Brain Iron Accumulation
  • An atypical and interesting feature of Parkinson´s disease
  • Patients with Essential Tremor Live Longer than their Relatives
  • Patients with Essential Tremor Live Longer than their Relatives
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley